Diabetes, Type I Clinical Trial
Official title:
A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 1 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Basal and Prandial Insulin Over a 52-Week Treatment Period and a 4-Week Follow Up
To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00328302 -
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
|
Phase 4 | |
| Completed |
NCT00541515 -
Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm
|
N/A | |
| Completed |
NCT00810589 -
A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
|
Phase 1 | |
| Completed |
NCT00046150 -
12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
|
Phase 3 | |
| Terminated |
NCT01129232 -
Diabetes Virus Detection Project, Intervention With GAD-alum
|
Phase 2 | |
| Recruiting |
NCT00804232 -
Childhood Diabetes
|
N/A | |
| Completed |
NCT00654121 -
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
|
Phase 2 | |
| Completed |
NCT01754259 -
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
|
Phase 3 |